Status:
COMPLETED
Intrapleural Bupivacaine for Ipsilateral Shoulder Pain After Thoracotomy
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Post Thoracic Surgery
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
While thoracic epidural could control incisional pain after thoracotomy, an excruciating ipsilateral shoulder pain happens post thoracotomy and could affect up to 85% of thoracotomy patients. It is of...
Eligibility Criteria
Inclusion
- Male and Female, between 18 and 80 years, ASA 1-3, Scheduled for open thoracotomy
Exclusion
- ASA \>3, morbid obesity BMI\>40, Previous cardiac or ipsilateral thoracic surgery, Renal or hepatic failure, anemia, allergy to local anesthetics, contraindications to receive regional anesthesia, patient refusal, reiteration due to complication
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2019
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT03862404
Start Date
July 1 2017
End Date
February 15 2019
Last Update
March 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montreal General Hospital
Montreal, Quebec, Canada, H3A 1A1